Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Emergent BioSolutions Inc (NYSE:EBS)

34.37
Delayed Data
As of Jun 28
 +1.17 / +3.52%
Today’s Change
24.47
Today|||52-Week Range
36.64
+4.66%
Year-to-Date
No recent news for Emergent BioSolutions Inc.

Today’s Trading

Previous close33.20
Today’s open33.47
Day’s range33.17 - 34.44
Volume271,877
Average volume (3 months)322,914
Market cap$1.4B
Dividend yield--
Data as of 4:02pm ET, 06/28/2017

Growth & Valuation

Earnings growth (last year)-19.86%
Earnings growth (this year)+1.73%
Earnings growth (next 5 years)+22.00%
Revenue growth (last year)-6.50%
P/E ratio26.2
Price/Sales3.31
Price/Book2.26

Competitors

 Today’s
change
Today’s
% change
INVAInnoviva Inc+0.32+2.54%
FOLDAmicus Therapeutics ...+0.04+0.41%
CORTCorcept Therapeutics...+0.29+2.48%
ARRYArray Biopharma Inc+0.09+1.06%
Data as of 4:00pm ET, 06/28/2017

Financials

Next reporting dateAugust 10, 2017
EPS forecast (this quarter)$0.17
Annual revenue (last year)$488.8M
Annual profit (last year)$51.8M
Net profit margin12.79%

Profile

Sector
Health Technology
Industry
Biotechnology
President, CEO &
Director
Daniel J. Abdun-Nabi
Executive VP-
Business Operations
Adam R. Havey
Corporate headquarters
Gaithersburg, Maryland

Forecasts